These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 30201570

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Well-plate freeze-drying: a high throughput platform for screening of physical properties of freeze-dried formulations.
    Trnka H, Rantanen J, Grohganz H.
    Pharm Dev Technol; 2015 Jan; 20(1):65-73. PubMed ID: 24417680
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Measurement of the kinetics of protein unfolding in viscous systems and implications for protein stability in freeze-drying.
    Tang XC, Pikal MJ.
    Pharm Res; 2005 Jul; 22(7):1176-85. PubMed ID: 16028019
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effects of formulation and process variables on the aggregation of freeze-dried interleukin-6 (IL-6) after lyophilization and on storage.
    Lueckel B, Helk B, Bodmer D, Leuenberger H.
    Pharm Dev Technol; 1998 Aug; 3(3):337-46. PubMed ID: 9742554
    [Abstract] [Full Text] [Related]

  • 27. The Influence of Mannitol Hemihydrate on the Secondary Drying Dynamics of a Protein Formulation: A Case Study.
    Srinivasan JM, Wegiel LA, Hardwick LM, Nail SL.
    J Pharm Sci; 2017 Dec; 106(12):3583-3590. PubMed ID: 28867201
    [Abstract] [Full Text] [Related]

  • 28. Characterization of the sucrose/glycine/water system by differential scanning calorimetry and freeze-drying microscopy.
    Kasraian K, Spitznagel TM, Juneau JA, Yim K.
    Pharm Dev Technol; 1998 May; 3(2):233-9. PubMed ID: 9653761
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Influence of the active pharmaceutical ingredient concentration on the physical state of mannitol--implications in freeze-drying.
    Liao X, Krishnamurthy R, Suryanarayanan R.
    Pharm Res; 2005 Nov; 22(11):1978-85. PubMed ID: 16132343
    [Abstract] [Full Text] [Related]

  • 31. Physicochemical characterization of the freezing behavior of mannitol-human serum albumin formulations.
    Hawe A, Friess W.
    AAPS PharmSciTech; 2006 Nov; 7(4):94. PubMed ID: 17285745
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Improved formulation and lyophilization cycle for rBCG vaccine.
    Jin TH, Nguyen L, Qu T, Tsao E.
    Vaccine; 2011 Jun 24; 29(29-30):4848-52. PubMed ID: 21549782
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Characterization of physical state of mannitol after freeze-drying: effect of acetylsalicylic acid as a second crystalline cosolute.
    Torrado S, Torrado S.
    Chem Pharm Bull (Tokyo); 2002 May 24; 50(5):567-70. PubMed ID: 12036006
    [Abstract] [Full Text] [Related]

  • 38. Development of freeze-dried biosynthetic Factor VIII: I. A case study in the optimization of formulation.
    Jameel F, Tchessalov S, Bjornson E, Lu X, Besman M, Pikal M.
    Pharm Dev Technol; 2009 May 24; 14(6):687-97. PubMed ID: 19883259
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.